B. Kuipers

发表

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.

J. Pennings, W. Jiskoot, G. Kersten, 2015, Journal of proteome research.

Bordetella pertussis Proteins Dominating the Major Histocompatibility Complex Class II-Presented Epitope Repertoire in Human Monocyte-Derived Dendritic Cells

C. Boog, A. D. de Jong, M. Poelen, 2014, Clinical and Vaccine Immunology.

Relative Immunogenicity of PorA Subtypes in a Multivalent Neisseria meningitidis Vaccine Is Not Dependent on Presentation Form

L. van Alphen, P. A. van der Ley, H. V. van Dijken, 2003, Infection and Immunity.

The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

E. Moxon, P. A. van der Ley, M. Jennings, 1999, Microbiology.

Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.

T. van der Poll, J. T. ten Cate, B. Biemond, 1998, American journal of respiratory and critical care medicine.

Multi-antigen immunization using IgG binding domain ZZ as carrier.

Yair Benita, W. Hennink, W. Jiskoot, 2005, Vaccine.

+ Meningococcal Peptides Recognized by CD4 Processed HLA Class II-Presented Mass Tag-Assisted Identification of Naturally

C. Boog, Gino Baart, H. Brugghe, 2005 .

Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.

P. A. van der Ley, H. Käyhty, L. Saarinen, 2001, Microbial pathogenesis.

Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

C. Boog, M. Poelen, C. V. van Els, 2010, Vaccine.

Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.

H. Valkenburg, J. Dankert, D. Caugant, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis

P. Hoogerhout, H. Brugghe, A. D. de Jong, 1995, Infection and immunity.

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine.

P. Roholl, P. A. van der Ley, J. Poolman, 1996, Vaccine.

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine.

L. van Alphen, R. de Groot, C. Vermont, 2001, Vaccine.

Multi‐component meningococcal serogroup B (MenB)‐4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency

S. Henriet, R. Groot, J. Langereis, 2019, Clinical and experimental immunology.

Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis

E. Sanders, C. V. van Els, A. B. Bonačić Marinović, 2017, Scientific Reports.

Phase variation in meningococcal lipooligosaccharide biosynthesis genes.

P. A. van der Ley, M. Jennings, A. Berrington, 2002, FEMS immunology and medical microbiology.

An improved whole cell pertussis vaccine with reduced content of endotoxin

D. S. Horton, B. Kuipers, A. V. D. van der Ark, 2013, Human vaccines & immunotherapeutics.

Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine

E. Sanders, M. Knol, G. Berbers, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine

M. Knol, B. Kuipers, N. Rots, 2015 .

A Novel Secondary Acyl Chain in the Lipopolysaccharide of Bordetella pertussis Required for Efficient Infection of Human Macrophages*

J. Tommassen, P. A. van der Ley, J. Geurtsen, 2007, Journal of Biological Chemistry.

Immunogenicity of Outer Membrane Proteins in a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis: Influence of Adjuvants on the Immune Response

L. van Alphen, P. A. van der Ley, L. Steeghs, 1999, Infection and Immunity.

Fast, Antigen-Saving Multiplex Immunoassay To Determine Levels and Avidity of Mouse Serum Antibodies to Pertussis, Diphtheria, and Tetanus Antigens

C. Boog, C. V. van Els, B. Kuipers, 2011, Clinical and Vaccine Immunology.

Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.

J. Tommassen, P. A. van der Ley, H. de Cock, 2000, FEMS immunology and medical microbiology.

Identification of a locus involved in meningococcal lipopolysaccharide biosynthesis by deletion mutagenesis

E. Moxon, P. A. van der Ley, M. Jennings, 1996, Molecular microbiology.

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies.

H. Valkenburg, J. Dankert, J. Poolman, 1994, Journal of medical microbiology.

Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine

P. A. van der Ley, J. Poolman, I. Claassen, 1997, Infection and immunity.

Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.

J. Poolman, P. Hoogerhout, H. Brugghe, 1997, FEMS immunology and medical microbiology.

Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine

P. A. van der Ley, J. Poolman, H. V. van Dijken, 1996, Infection and immunity.

Serological characterization.

L. van Alphen, B. Kuipers, G. P. van den Dobbelsteen, 2001, Methods in molecular medicine.

Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific

J. Tommassen, J. Poolman, R. Tiesjema, 1990, Infection and immunity.

The purification and protective capacity of Bordetella pertussis outer membrane proteins.

J. Poolman, B. Kuipers, H. Hamstra, 1995, Vaccine.

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age.

L. van Alphen, R. de Groot, H. V. van Dijken, 2000, Vaccine.

Li po - o 1 i g osa cc ha ride i m m u n oty p i n g of Neisseria meningitidis by a whole-cell ELISA with monoclonal anti bodies

H. Valkenburg, B. Kuipers, R. Scholten, 1994 .

Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine

D. Caugant, C. Vermont, H. V. van Dijken, 2003, Infection and Immunity.

Coincorporation of LpxL1 and PagL Mutant Lipopolysaccharides into Liposomes with Neisseria meningitidis Opacity Protein: Influence on Endotoxic and Adjuvant Activity

J. Tommassen, P. A. van der Ley, H. V. van Dijken, 2010, Clinical and Vaccine Immunology.

Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens.

J. Nagel, J. Poolman, B. Kuipers, 1990, Microbial pathogenesis.

Mass Tag-Assisted Identification of Naturally Processed HLA Class II-Presented Meningococcal Peptides Recognized by CD4+ T Lymphocytes

C. Boog, Gino Baart, H. Brugghe, 2005, The Journal of Immunology.

T Lymphocytes + Meningococcal Peptides Recognized by CD 4 Processed HLA Class II-Presented Mass Tag-Assisted Identification of Naturally

C. Boog, Gino Baart, H. Brugghe, 2005 .

Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface

E. Pinelli, S. Rooijakkers, B. Kuipers, 2017, PLoS pathogens.

Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection

J. Pennings, W. Jiskoot, G. Kersten, 2014, PloS one.

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections

P. Teunis, F. Versteegh, G. Berbers, 2016, PloS one.

Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines.

J. Pennings, J. van den Ijssel, L. A. van der Pol, 2017, Journal of proteome research.

Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design.

P. Gros, G. Vidarsson, L. van Alphen, 2005, Journal of molecular biology.

Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations.

Alexandre M J J Bonvin, Piet Gros, A. Bonvin, 2003, Journal of molecular biology.

Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis

C. Boog, J. V. van Putten, M. Poelen, 2010, PloS one.

Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.

J. Tommassen, R. Vandebriel, J. Geurtsen, 2008, Vaccine.

Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity of Bordetella pertussis

J. Tommassen, J. Geurtsen, L. Steeghs, 2006, Infection and Immunity.

Consequences of the expression of lipopolysaccharide-modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines.

J. Tommassen, R. Vandebriel, J. Geurtsen, 2007, Microbes and infection.

Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.

T. van der Poll, J. T. ten Cate, S. Deventer, 1994, Journal of immunology.

Bordetella pertussis Naturally Occurring Isolates with Altered Lipooligosaccharide Structure Fail To Fully Mature Human Dendritic Cells

F. Mooi, C. V. van Els, J. Brummelman, 2014, Infection and Immunity.

Maarten Schipper, C. Boog, F. Versteegh, 2014, PloS one.

Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin

F. Mooi, C. Boog, M. Hijnen, 2008, Infection and Immunity.

Long Lasting Antibodies From Convalescent Pertussis Patients Induce ROS Production and Bacterial Killing by Human Neutrophils

R. Jacobi, C. V. van Els, E. Pinelli, 2022, Frontiers in Cellular and Infection Microbiology.

Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients

D. Hijdra, C. V. van Els, E. Pinelli, 2018, Scientific Reports.